Table 2.
Detail Characteristics of Patients based on Relapse and Remission Groups
| Scale/variable | Relapse group | Remission group | Total N (%) | p-value | |
|---|---|---|---|---|---|
| Age | Mean ± SD | 41 ± 15.65 | 26 ± 14.72 | 34.03 ± 15.78 | 0.006 |
| Gender N (%) | Male | 28 (35.5) | 51 (64.5) | 79 (79) | 0.47 |
| Female | 5 (23.9) | 16 (76.1) | 21 (21) | ||
| Tumor type % | Classic | 29.20% | 70.80% | 24 (24) | 0.17 |
| Nodular Sclerosis | 26.10% | 73.90% | 46 (46) | ||
| Mixed Cellularity | 47.80% | 52.20% | 23 (23) | ||
| Lymphocyte-Rich | 60% | 40% | 5 (5) | ||
| Lymphocyte-Depleted | 50% | 50% | 2 (2) | ||
| Numerical stage | Mean ± SD | 2.8±0.92 | 2.2±1.01 | 2.4±1.04 | 0.004 |
| PD-L1 expression | Positive N (%) | 23 (69.7%) | 26 (38.8%) | 49 (49) | 0.03 |
| Negative N (%) | 10 (19.6%) | 41 (80.4%) | 51 (51) | ||
| TPS scoring | Mean ± SD | 42.68±33.23 | 19.2±27.86 | 27.2±31.76 | 0.003 |
| Not expressed N (%) | 10 (19.6) | 41 (80.4) | 51 (51) | - | |
| Low expression N (%) | 5 (21.7) | 18 (78.3) | 23 (23) | ||
| High expression N (%) | 18 (69.2) | 8 (31.8) | 26 (26) |